Compared to healthy individuals, DLBCL patients have lower levels of CD3+ T cells, CD4+ T cells, and CD8+ T cells, with these counts decreasing as the IPI score increases (8, 67). The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.